Close this search box.

ERS 2022 Brand Buzz

Online analysis based on ERS 2022 mentions
in the period 28 August – 10 September 2022

04 – 06 SEPT


This year’s European Respiratory Society’s Congress (ERS) was held in Barcelona, Spain. The event welcomed thousands of delegates to unravel the newest advances in respiratory medicine and science.  The scientific programme featured cutting-edge scientific sessions, practical workshops, interactive educational content and networking opportunities for visitors and companies that both exhibited and attended the congress.

Activity Over Time

Volume over time is tracked back to one month before the event when most exhibitors started announcing their participation.

Key Event Topics

Relative shares (in percents) are calculated out of all categorised posts within the respective social media.

In comparison to last year’s ERS Brand Buzz Report, the top 5 most discussed topics have changed slightly. With COVID-19 now taking the third place, followed by Training & Education and Innovations in Sleep Care & Therapy, the first and second places are taken by two brand new topics—Sleep-Related Disorders and Treatment of Sleep Disorders (including medication).

In Twitter only, COVID-19 ranked higher than Training Education & Innovations.

* Relative shares are calculated out of all categorised posts within the respective social media.

Competitive Brand Buzz

The top brands that have generated the most engagement with their social media activity – likes, comments, reshares, etc

Influencers & Online Buzz Strategies

What did the highest-ranking companies in Brand Buzz analysis talk about? 


Chiesi’s focus during this year’s ERS Congress narrowed to three different areas of study, but what stood out was the company’s dedication to co-creating smart and human solutions. The company supported the launch of the new International Respiratory Coalition ‘Lung Facts’ – a web-based tool with key economical and epidemiological data for respiratory conditions across Europe.


GSK’s top voices—Dr. Susie Barnes, Dr. Marco Avila and Dr. Piyali Mukherjee presented 31 abstracts from the brand’s portfolio of biologics, vaccines and inhaled medicines. Their research aims to redefine what is possible for patients.


AstraZeneca took a closer look at chronic respiratory and immune-mediated diseases. The company strives to transform care, with bold ambition to go beyond controlling symptoms, to slow down or reverse the course of disease.

TOP 10 Influencers by Conversation Impact

Marko Topalovic

Helps interpretation of pulmonary function tests | Co-Founder & CEO at ArtiQ

Paul Rowe, MD, ATSF

Vice President, Head of Global Medical, Immunology at Sanofi

Jason Weatherald

Assistant Professor at University of Calgary

James D Chalmers

Asthma and Lung UK Chair of Respiratory Research, University of Dundee. Deputy Editor of ERJ.

Ayodeji Adegunsoye MD FACP FCCP

Assistant Professor at University of Chicago

Alexandre Kawassaki

LinkedIn TopVoice Saúde 2020. Pneumologista do Grupo de Doenças Intersticiais – HCFMUSP, na Clínica de Doenças Respiratórias Avançadas, no Hospital 9 de Julho e no Hospital Israelita Albert Einstein

Hari Kishan Gonuguntla

Lead Consultant – Interventional Pulmonology at Yashoda Hospitals

Tommaso Scquizzato

Cardiac Arrest Researcher | Named 40 Under 40 for Cardiac Arrest | Studying how to restart hearts that suddenly stop

Eline van der Ploeg

AIOS Longziekten en Tuberculose bij UMCG Universitair Medisch Centrum Groningen

Dr. Samir Nusair, MD

MD at Clalit Health Services

Top Buzz-Generating Posts